Company news
Bioasis Technologies Inc. news in 2020
Bioasis Technologies Inc.'s news releases, calls and decks from 2020, newest first.
Bioasis Announces Sale of Royalty Interest in Lysosomal Storage Disorder Enzymes Being Developed Under the Chiesi Group–Bioasis Strategic Alliance to XOMA Corporation
November 3, 2020
Bioasis Announces Filing of Its Quarterly Financial Statements and MD&A for the Period Ending August 31, 2020
October 29, 2020
Bioasis Announces Analyst Coverage Initiated by Zacks Investment Research
October 22, 2020
Bioasis Announces Issuance of US Patent Relating to xB³™ Platform Technology for The Delivery of Therapeutic Agents Across the Blood-Brain Barrier
October 20, 2020
Bioasis Announces Filing of Its Quarter and Financial Statements and MD&A for the Period Ending May 31, 2020
July 27, 2020
Bioasis and Chiesi Group to Host Webcast on July 16, 2020
July 9, 2020
Bioasis Announces Stock Option Grants
July 7, 2020
Bioasis and Chiesi Group Announce Rare Diseases Strategic Alliance
June 29, 2020
Bioasis Announces Conversion of Debenture Interest Into Equity
June 24, 2020
Bioasis Announces Analyst Coverage Initiated by Edison Group
June 17, 2020
Bioasis Completes Redemption of 15% Unsecured Debentures With Unanimous Debentureholder Approval
April 6, 2020
Bioasis Announces Proposed Redemption of 15% Unsecured Debentures
March 6, 2020
Bioasis Technologies Announces the Appointment of Dr. May Orfali to the Position of Consultant Chief Medical Officer
March 4, 2020
Growth Company Investor Presentations Now Available for On-Demand Viewing
February 24, 2020
Bioasis to Present at the OTC Markets 2020 Virtual Investor Conference
February 19, 2020
Live Investor Conference & Webinar: Growth Company CEOs Present February 20th
February 14, 2020
Bioasis to Present at the 22nd Annual BIO CEO Investor Conference and the OTC Markets 2020 Virtual Investor Conference
February 6, 2020
Bioasis Announces Filing of Its Quarterly Financial Statements and MD&A for the Period Ending November 30, 2019
January 29, 2020